Serologicals Acquires Upstate and Will Issue Shares to Molecular Devices

Serologicals will acquire Upstate Group for $205 million in stock and cash, according to SEC documents filed this week.

As part of the acquisition, Serologicals will issue shares to Molecular Devices and other Upstate shareholders, the company said in its 8-K filing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.